SwePub
Sök i SwePub databas

  Utökad sökning

Träfflista för sökning "WFRF:(Israel Carsten) "

Sökning: WFRF:(Israel Carsten)

  • Resultat 1-10 av 19
  • [1]2Nästa
Sortera/gruppera träfflistan
   
NumreringReferensOmslagsbildHitta
1.
  •  
2.
  •  
3.
  •  
4.
  • Boriani, Giuseppe, et al. (författare)
  • Safety and efficacy of dronedarone from clinical trials to real-world evidence : implications for its use in atrial fibrillation
  • 2019
  • Ingår i: Europace. - : Oxford University Press. - 1099-5129 .- 1532-2092. ; 21:12, s. 1764-1775
  • Tidskriftsartikel (refereegranskat)abstract
    • Efficacy and safety of dronedarone was shown in the ATHENA trial for paroxysmal or persistent atrial fibrillation (AF) patients. Further trials revealed safety concerns in patients with heart failure and permanent AF. This review summarizes insights from recent real-world studies and meta-analyses, including reports on efficacy, with focus on liver safety, mortality risk in patients with paroxysmal/persistent AF, and interactions of dronedarone with direct oral anticoagulants. Reports of rapidly progressing liver failure in dronedarone-prescribed patients in 2011 led to regulatory cautions about potential liver toxicity. Recent real-world evidence suggests dronedarone liver safety profile is similar to other antiarrhythmics and liver toxicity could be equally common with many Class III antiarrhythmics. Dronedarone safety concerns (increased mortality in patients with permanent AF) were raised based on randomized controlled trials (RCT) (ANDROMEDA and PALLAS), but comedication with digoxin may have increased the mortality rates in PALLAS, considering the dronedarone-digoxin pharmacokinetic (PK) interaction. Real-world data on apixaban-dronedarone interactions and edoxaban RCT observations suggest no significant safety risks for these drug combinations. Median trough plasma concentrations of dabigatran 110 mg during concomitant use with dronedarone are at acceptable levels, while PK data on the rivaroxaban-dronedarone interaction are unavailable. In RCTs and real-world studies, dronedarone significantly reduces AF burden and cardiovascular hospitalizations, and demonstrates a low risk for proarrhythmia in patients with paroxysmal or persistent AF. The concerns on liver safety must be balanced against the significant reduction in hospitalizations in patients with non-permanent AF and low risk for proarrhythmias following dronedarone treatment.
  •  
5.
  •  
6.
  •  
7.
  •  
8.
  •  
9.
  • Dickstein, Kenneth, et al. (författare)
  • CRT Survey II : a European Society of Cardiology survey of cardiac resynchronisation therapy in 11 088 patients-who is doing what to whom and how?
  • 2018
  • Ingår i: European Journal of Heart Failure. - : WILEY. - 1388-9842 .- 1879-0844. ; 20:6, s. 1039-1051
  • Tidskriftsartikel (refereegranskat)abstract
    • Background Cardiac resynchronisation therapy (CRT) reduces morbidity and mortality in appropriately selected patients with heart failure and is strongly recommended for such patients by guidelines. A European Society of Cardiology (ESC) CRT survey conducted in 2008-2009 showed considerable variation in guideline adherence and large individual, national and regional differences in patient selection, implantation practice and follow-up. Accordingly, two ESC associations, the European Heart Rhythm Association and the Heart Failure Association, designed a second prospective survey to describe contemporary clinical practice regarding CRT. Methods and results A survey of the clinical practice of CRT-P and CRT-D implantation was conducted from October 2015 to December 2016 in 42 ESC member countries. Implanting centres provided information about their hospital and CRT service and were asked to complete a web-based case report form collecting information on patient characteristics, investigations, implantation procedures and complications during the index hospitalisation. The 11 088 patients enrolled represented 11% of the total number of expected implantations in participating countries during the survey period; 32% of patients were aged >= 75 years, 28% of procedures were upgrades from a permanent pacemaker or implantable cardioverter-defibrillator and 30% were CRT-P rather than CRT-D. Most patients (88%) had a QRS duration >= 130 ms, 73% had left bundle branch block and 26% were in atrial fibrillation at the time of implantation. Large geographical variations in clinical practice were observed. Conclusion CRT Survey II provides a valuable source of information on contemporary clinical practice with respect to CRT implantation in a large sample of ESC member states. The survey permits assessment of guideline adherence and demonstrates variations in patient selection, management, implantation procedure and follow-up strategy.
  •  
10.
  • Emmelmann, Marc, et al. (författare)
  • Deliverable 6.2: Trials and experimentation (cycle 2)
  • 2020
  • Rapport (refereegranskat)abstract
    • This deliverable presents the second cycle of trials and experimentation activities executed over 5GENESIS facilities. The document is the continuation of deliverable D6.1, in the sense that it captures tests carried out over the evolved infrastructures hosting 5GENESIS facilities following the methodology defined in D6.1. In this document 8 main KPIs and 4 application specific validation trials achieved, under 123 experiments that performed in total. The tests focus more on i) the evolved 5G infrastructure deployments that includes radio and core elements in non-standalone (NSA) deployment configurations based on commercial and open implementations, and ii) the use of Open 5GENESIS Suite for the execution of the tests.
  •  
Skapa referenser, mejla, bekava och länka
  • Resultat 1-10 av 19
  • [1]2Nästa
Typ av publikation
tidskriftsartikel (16)
forskningsöversikt (2)
rapport (1)
Typ av innehåll
refereegranskat (18)
övrigt vetenskapligt (1)
Författare/redaktör
Boriani, Giuseppe (10)
Israel, Carsten W (10)
Leclercq, Christophe (9)
Auricchio, Angelo (9)
Linde, Cecilia (8)
Delgado, Victoria (6)
visa fler...
Brignole, Michele (6)
Blomström-Lundqvist, ... (5)
Dickstein, Kenneth (5)
Mont, Lluis (5)
Israel, Carsten (5)
Deharo, Jean-Claude (4)
Lip, Gregory Y H (4)
Merkely, Bela (4)
Vardas, Panos E (4)
Vardas, Panos (4)
Ruschitzka, Frank (3)
Goette, Andreas (3)
Nielsen, Jens Cosedi ... (3)
Camm, A. John (3)
Kalarus, Zbigniew (3)
Braunschweig, Friede ... (2)
Jaarsma, Tiny (2)
Zamorano, Jose Luis (2)
Lindenfeld, JoAnn (2)
Coats, Andrew J. S. (2)
Lund, Lars H. (2)
Mullens, Wilfried (2)
Seferovic, Petar (2)
Coats, Andrew (2)
Burri, Haran (2)
Vernooy, Kevin (2)
Leyva, Francisco (2)
Michowitz, Yoav (2)
Kronborg, Mads Brix (2)
Glikson, Michael (2)
Thylén, Ingela (2)
Donal, Erwan (2)
Edvardsen, Thor (2)
Keren, Andre (2)
Diller, Gerhard-Paul (2)
Wegscheider, Karl (2)
Kirchhof, Paulus (2)
Heidbuchel, Hein (2)
Barrabes, Jose A. (2)
Calkins, Hugh (2)
Traykov, Vassil (2)
Starck, Christoph (2)
Kuck, Karl-Heinz (2)
Botto, Giovanni L (2)
visa färre...
Lärosäte
Uppsala universitet (11)
Linköpings universitet (5)
Karolinska Institutet (3)
Göteborgs universitet (2)
Umeå universitet (1)
Lunds universitet (1)
visa fler...
Karlstads universitet (1)
visa färre...
Språk
Engelska (19)
Forskningsämne (UKÄ/SCB)
Medicin och hälsovetenskap (10)
Naturvetenskap (2)
Teknik (1)

År

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Stäng

Kopiera och spara länken för att återkomma till aktuell vy